Identifying new targets for treating metastatic colorectal cancer
Targeting the evolving immunopeptidome of metastatic colorectal cancer
This study is looking for special markers in advanced colorectal cancer that could help create better treatments using CAR T cell therapy, aiming to find targets that are unique to cancer cells and not found in healthy tissues, so patients can have more effective options for their care.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11035804 on NIH RePORTER |
What this research studies
This research investigates the immunopeptidome of metastatic colorectal cancer (mCRC) to find specific targets for chimeric antigen receptor (CAR) T cell therapies. By analyzing peptides presented by human leukocyte antigen (HLA) class I molecules, the study aims to uncover cancer-specific antigens that could improve treatment outcomes. The researchers will utilize patient-derived organoids to model the disease and identify unique peptide targets that are prevalent in cancer cells but absent in healthy tissues. This approach seeks to enhance the effectiveness of immunotherapy for patients with advanced colorectal cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with metastatic colorectal cancer who are HLA-A*02:01 positive.
Not a fit: Patients with early-stage colorectal cancer or those who do not express the HLA-A*02:01 allele may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective immunotherapies for patients with metastatic colorectal cancer.
How similar studies have performed: Other research has shown promise in targeting the immunopeptidome in various cancers, suggesting that this approach could be effective for colorectal cancer as well.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Lee, Jaeyop — Sloan-Kettering Inst Can Research
- Study coordinator: Lee, Jaeyop
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.